Insights

Recent Acquisition The company was acquired by PolyPlus Battery Company, a leader in cell and gene therapy solutions, indicating strategic integration into a broader biotech and advanced therapeutics ecosystem, which presents cross-selling opportunities for additional biotech services and collaborations.

Niche Expertise Specialized in microbial expression systems for the production of recombinant proteins, antibody fragments, and plasmid DNA, offering reliable, scalable, and IP-free processes that cater to preclinical and early-stage clinical development, ideal for clients seeking tailored biologics manufacturing solutions.

Growth Potential With a revenue range of up to one million dollars and a small, agile team, there is potential for expansion in service offerings such as GMP-grade material production, clinical study organization, and antibody screening, making it attractive for companies looking for flexible, innovative biotech partners.

Service Flexibility Xpress Biologics functions as a one-stop shop with project management capabilities, enabling clients to outsource a broad spectrum of biologics development activities, which can be leveraged to target biotech firms seeking comprehensive, end-to-end contract manufacturing and development solutions.

Market Positioning Operating in a competitive landscape with companies like Abzena and Agenus, Xpress Biologics' focus on microbial expression and early-stage production positions it as a specialized partner for emerging biotech and gene therapy companies needing cost-effective, regulatory-compliant biologics manufacturing.

Similar companies to Sartorius Xpress Biologics

Sartorius Xpress Biologics Tech Stack

Sartorius Xpress Biologics uses 8 technology products and services including Open Graph, Salesforce, Microsoft 365, and more. Explore Sartorius Xpress Biologics's tech stack below.

  • Open Graph
    Content Management System
  • Salesforce
    Customer Relationship Management
  • Microsoft 365
    Email
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology
  • Google Analytics
    Web Analytics
  • Adobe Fonts
    Web Fonts

Sartorius Xpress Biologics's Email Address Formats

Sartorius Xpress Biologics uses at least 1 format(s):
Sartorius Xpress Biologics Email FormatsExamplePercentage
F.Last@xpress-biologics.comJ.Doe@xpress-biologics.com
50%
F.Last@xpress-biologics.comJ.Doe@xpress-biologics.com
50%

Frequently Asked Questions

What is Sartorius Xpress Biologics's official website and social media links?

Minus sign iconPlus sign icon
Sartorius Xpress Biologics's official website is xpress-biologics.com and has social profiles on LinkedIn.

What is Sartorius Xpress Biologics's SIC code NAICS code?

Minus sign iconPlus sign icon
Sartorius Xpress Biologics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sartorius Xpress Biologics have currently?

Minus sign iconPlus sign icon
As of December 2025, Sartorius Xpress Biologics has approximately 28 employees across 2 continents, including EuropeNorth America. Key team members include Scientist/Project Leader In Biochemistry: M. E.Quality Control Manager: C. D.Project Leader: P. Z.. Explore Sartorius Xpress Biologics's employee directory with LeadIQ.

What industry does Sartorius Xpress Biologics belong to?

Minus sign iconPlus sign icon
Sartorius Xpress Biologics operates in the Biotechnology Research industry.

What technology does Sartorius Xpress Biologics use?

Minus sign iconPlus sign icon
Sartorius Xpress Biologics's tech stack includes Open GraphSalesforceMicrosoft 365jQueryPHPX-Content-Type-OptionsGoogle AnalyticsAdobe Fonts.

What is Sartorius Xpress Biologics's email format?

Minus sign iconPlus sign icon
Sartorius Xpress Biologics's email format typically follows the pattern of F.Last@xpress-biologics.com. Find more Sartorius Xpress Biologics email formats with LeadIQ.

When was Sartorius Xpress Biologics founded?

Minus sign iconPlus sign icon
Sartorius Xpress Biologics was founded in 2014.

Sartorius Xpress Biologics

Biotechnology ResearchWallonia, Belgium11-50 Employees

Sartorius Xpress Biologics, is a biotech company proposing contract services for the production of recombinant proteins, antibody fragments and plasmid DNA for preclinical applications (therapeutic and diagnostic markets). The production scale goes from 100 mg up to 10 g with, depending of the use of the biologics, “R&D” and “GLP” qualities.  The production processes proposed by Xpress Biologics are all developed in microbial expression system, E. coli (soluble cytoplasmic, inclusion bodies and periplasmic productions) and P. pastoris (secreted protein) mainly.

These processes are IP free and take into account the regulatory and industrial (scale-up) requirements which facilitate the transfer of the project to CMOs (Contract Manufacturing Organizations) for the production of “GMP” grade material if necessary.

Xpress Biologics acts as One-Stop-Shop and can, through project management with defined subcontractors, take in charge additional services as the screening and development of antibodies against specific targets, the production of “GMP” grade material, the organization of pre-clinical and clinical studies.

We wanted to share that we will not be actively posting or engaging on this LinkedIn account. However, you can continue to stay updated and connect with us over https://www.linkedin.com/showcase/106511553

We appreciate all the conversations and connections we’ve built here and look forward to continuing them on our other page.

Thank you for your support, and we hope to see you there!

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $1M

    Sartorius Xpress Biologics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Sartorius Xpress Biologics's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.